Breathe Well Live Well
|
ALK's Grazax fails to prevent asthma, but reduces symptoms
PharmaTimes On the plus side, treatment with Grazax did have a positive effect on the children's asthma symptoms and use of asthma medication; the odds ratio for these at the end of the five-year evaluation period was 0.66 in favour of ALK's therapy, the firm said. |
View full post on asthma – Google News
|
Two million unaware of asthma attack risk
PharmaTimes More than half of people with asthma (52%) don't think they are at risk of an attack — but in reality nine out of ten of those people are mistaken, according to new data from the charity. This means that nearly half of all adults with asthma – or more … |
View full post on asthma – Google News
|
NICE U-turn on Novartis' Xolair for asthma
PharmaTimes The National Institute for Health and Clinical Excellence said it now recommends Xolair (omalizumab) as an option for treating severe, persistent allergic asthma in adults, adolescents and children, in a complete turnaround from its earlier intention … Asthma treatment – double U-turn Life-changing jab gives hope to asthma sufferers NICE approves use of asthma drug omalizumab |
View full post on asthma – Google News
|
NICE's new asthma quality standard "could change millions of lives"
PharmaTimes Patient groups have welcomed the National Institute for Health and Clinical Excellence (NICE)'s new quality standard for asthma care, with Asthma UK stating that, if successful, it "could change millions of lives." The quality standard, which covers … New integrated approach to asthma care New asthma care 'could change millions of lives' |
View full post on asthma – Google News
|
Olympian backs Asthma UK campaign
PharmaTimes The Olympian, who was recently made an OBE, defied the odds to become a cycling champion after she was born with a collapsed lung and developed severe asthma. Laura, 20, says she now wants to inspire other young people with asthma by supporting … |
View full post on asthma – Google News